Francisco Partners to Acquire IBM’s Healthcare Data and Analytics Assets
21 Janeiro 2022 - 10:00AM
Business Wire
Upon close, acquisition to position new
standalone company for next phase of growth
IBM (NYSE: IBM) and Francisco Partners, a leading global
investment firm that specializes in partnering with technology
businesses, today announced that the companies have signed a
definitive agreement under which Francisco Partners will acquire
healthcare data and analytics assets from IBM that are currently
part of the Watson Health business. The assets acquired by
Francisco Partners include extensive and diverse data sets and
products, including Health Insights, MarketScan, Clinical
Development, Social Program Management, Micromedex, and imaging
software offerings.
The transaction is expected to close in the second quarter of
this year and is subject to customary regulatory clearances.
Financial terms of the transaction were not disclosed.
“Today’s agreement with Francisco Partners is a clear next step
as IBM becomes even more focused on our platform-based hybrid cloud
and AI strategy,” said Tom Rosamilia, Senior Vice President, IBM
Software. “IBM remains committed to Watson, our broader AI
business, and to the clients and partners we support in healthcare
IT. Through this transaction, Francisco Partners acquires data and
analytics assets that will benefit from the enhanced investment and
expertise of a healthcare industry focused portfolio.”
Since its launch over 20 years ago, Francisco Partners has
invested in over 400 technology companies, making it one of the
most active and longstanding investors in the technology industry.
Francisco Partners has extensive experience in healthcare
technology and its healthcare investments have focused on companies
that are leveraging technology to provide innovative products and
solutions to the healthcare ecosystem including patients,
providers, payers, pharma, life sciences and governments. Select
current and past investments in the sector include Availity,
eSolutions, Capsule, GoodRx, Landmark, QGenda, Trellis, and
Zocdoc.
“We have followed IBM’s journey in healthcare data and analytics
for a number of years and have a deep appreciation for its
portfolio of innovative healthcare products,” said Ezra Perlman,
Co-President at Francisco Partners. “IBM built a market leading
team and provides its customers with mission critical products and
outstanding service.”
Justin Chen, Principal at Francisco Partners, added, “Partnering
with corporations to execute divisional carve-outs has been a core
focus of Francisco Partners. We look forward to supporting the
talented employees and management team, helping the standalone
company focus on growth opportunities to realize its full
potential, and delivering enhanced value to customers and
partners.”
Under the terms of the agreement, the current management team
will continue in similar roles in the new standalone company,
serving existing clients in life sciences, provider, imaging, payer
and employer, and government health and human services sectors.
About Francisco Partners Francisco Partners is a leading
global investment firm that specializes in partnering with
technology and technology-enabled businesses. Since its launch over
20 years ago, Francisco Partners has invested in over 400
technology companies, making it one of the most active and
longstanding investors in the technology industry. With more than
$30 billion in assets under management, the firm invests in
opportunities where its deep sectoral knowledge and operational
expertise can help companies realize their full potential. For more
information on Francisco Partners, please visit
www.Franciscopartners.com.
About IBM For more information about IBM visit,
www.ibm.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220121005144/en/
Media
For IBM: Tim Davidson tfdavids@us.ibm.com
914-844-7847
For Francisco Partners: Whit Clay wclay@sloanepr.com
Kate Sylvester ksylvester@sloanepr.com
International Business M... (NYSE:IBM)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
International Business M... (NYSE:IBM)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024